Skip to content

Clinical trials

Terminated Hypertension, Pulmonary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Status: Terminated Country / region: United States Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20067
20075
20087
20096
20108
20117
20122
20132
20144
20151
20164
20176
20186
20195
20201
20212
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated82

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics9
Novartis Pharmaceuticals6
Actelion4
NICHD Neonatal Research Network4
Pfizer4
University of North Carolina, Chapel Hill3
Bayer2
Biogen2
Children's Hospital of Philadelphia2
Complexa, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary82
Pulmonary Arterial Hypertension28
Lung Diseases6
Pulmonary Disease, Chronic Obstructive6
Anemia, Sickle Cell5
Familial Primary Pulmonary Hypertension5
Hypertension5
Persistent Fetal Circulation Syndrome4
Respiratory Insufficiency4
Vascular Diseases4

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.